Search Results - Litha Jaison
- Showing 1 - 2 results of 2
-
1
Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar by Herve Bischoff, Neil K. O’Connor, Jamie Kim, Bogdan V. Popescu, Cecile Bigot, Sumita Pradhan, Rusha Chakraborty, Litha Jaison, Fathima Majeed, Lisa S. Park, Lotfi Boudali, Alexandre Detappe, Xavier Pivot, Pierre Coliat
Published in Drugs in R&D (2025-04-01)Get full text
Article -
2
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting by Xavier Pivot, Alexey Georgievitch Manikhas, Volodymyr Shamrai, Giorgi Dzagnidze, Hwoei Fen Soo Hoo, Viriya Kaewkangsadan, Fausto Petrelli, Cristian Villanueva, Jamie Kim, Sumita Pradhan, Litha Jaison, Peggy Feyaerts, Leonard Kaufman, Marie-Paule Derde, Filip Deforce, David G. Cox
Published in BMC Cancer (2023-01-01)Get full text
Article
